Adeno-associated virus as a delivery vector for gene therapy of human diseases
JH Wang, DJ Gessler, W Zhan, TL Gallagher… - Signal Transduction and …, 2024 - nature.com
Adeno-associated virus (AAV) has emerged as a pivotal delivery tool in clinical gene
therapy owing to its minimal pathogenicity and ability to establish long-term gene expression …
therapy owing to its minimal pathogenicity and ability to establish long-term gene expression …
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments
C Happi Mbakam, JP Tremblay - Expert Review of …, 2023 - Taylor & Francis
Introduction Duchenne muscular dystrophy (DMD) is one of the most severe and devastating
neuromuscular hereditary diseases with a male newborn incidence of 20 000 cases each …
neuromuscular hereditary diseases with a male newborn incidence of 20 000 cases each …
Cardiac therapies for Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a devastating disease that results in life-limiting
complications such as loss of skeletal muscle function as well as respiratory and cardiac …
complications such as loss of skeletal muscle function as well as respiratory and cardiac …
Interspecies Scaling of Transgene Products for Viral Vector Gene Therapies: Method Assessment Using Data from Eleven Viral Vectors
The prediction of transgene product expression in human is important to guide first-in-
human (FIH) dose selection for viral vector-based gene replacement therapies. Recently …
human (FIH) dose selection for viral vector-based gene replacement therapies. Recently …
Diagnostic accuracy of CK-MM test in newborn screening for DMD: A systematic review and meta-analysis
L Tang, M Pan, F Wu - Pediatric Neurology, 2024 - Elsevier
Aim To systematically evaluate the diagnostic accuracy of the creatine kinase isoenzyme-
MM (CK-MM) test in newborn screening for Duchenne Muscular Dystrophy (DMD). Methods …
MM (CK-MM) test in newborn screening for Duchenne Muscular Dystrophy (DMD). Methods …
Diagnostic Accuracy of Creatine Kinase Isoenzyme-MM Test in Newborn Screening for Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis
L Tang, M Pan, F Wu - Pediatric Neurology, 2024 - pedneur.com
Background To systematically evaluate the diagnostic accuracy of the creatine kinase
isoenzyme-MM (CK-MM) test in newborn screening for Duchenne muscular dystrophy …
isoenzyme-MM (CK-MM) test in newborn screening for Duchenne muscular dystrophy …
A comprehensive review of Duchenne muscular dystrophy: genetics, clinical presentation, diagnosis, and treatment
KA Limback, WD Jacobus… - Biotechnology …, 2022 - digitalcommons.kansascity.edu
Abstract Duchenne Muscular Dystrophy (DMD) is a genetic disorder involving progressive
muscle deterioration leading to loss of mobility, cardiomyopathy, and respiratory …
muscle deterioration leading to loss of mobility, cardiomyopathy, and respiratory …
Molecular Genetic Therapies in the Muscular Dystrophies
S Nicolau, KM Flanigan - Principles and Practice of the Muscular …, 2024 - Springer
The identification of the genes causing the most common muscular dystrophies over the past
few decades has allowed the design of new classes of targeted therapeutics. A number of …
few decades has allowed the design of new classes of targeted therapeutics. A number of …
The Sda Carbohydrate Antigen and Its Biosynthetic Enzyme B4GALNT2 in Health and Disease.
M Duca, N Malagolini, F Dall'Olio - 2024 - preprints.org
The carbohydrate antigen Sda is expressed on cells and secretions of the vast majority of
Caucasians. The epitope is formed by a terminal GalNAc residue β4-linked to a α3 …
Caucasians. The epitope is formed by a terminal GalNAc residue β4-linked to a α3 …